We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
(-4.4%)
Cap. Flow
+$802M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$78.7M |
| 2 |
XYZ
Block Inc
XYZ
|
+$49.3M |
| 3 |
Visa
V
|
+$46.1M |
| 4 |
Apple
AAPL
|
+$45.4M |
| 5 |
DoorDash
DASH
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$78.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$23.2M |
| 3 |
Williams-Sonoma
WSM
|
+$22.2M |
| 4 |
Broadcom
AVGO
|
+$20.3M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.67% |
| 2 | Financials | 14.43% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Torrid Holdings
CURV
$260M
| $120K | ﹤0.01% |
21,886
+4,673
| +27% | +$28K |
|
3052
Coherus Oncology
CHRS
$196M
| $120K | ﹤0.01% |
148,494
-6,707
| -4% | -$7.72K |
|
|
VCSA
3053
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $120K | ﹤0.01% |
22,229
-143
| -0.6% | -$739 |
|
3054
Sight Sciences
SGHT
$412M
| $120K | ﹤0.01% |
49,797
+4,319
| +9% | +$12.2K |
|
3055
Sun Life Financial
SLF
$45.4B
| $119K | ﹤0.01% |
2,082
| – | – |
|
3056
Fate Therapeutics
FATE
$326M
| $119K | ﹤0.01% |
150,248
-8,924
| -6% | -$10.9K |
|
3057
Eve Holding
EVEX
$962M
| $117K | ﹤0.01% |
35,223
+7,154
| +25% | +$30.9K |
|
3058
Empire Petroleum
EP
$111M
| $116K | ﹤0.01% |
18,506
+1,122
| +6% | +$7.21K |
|
|
TEM
3059
Tempus AI
TEM
$9.39B
| $116K | ﹤0.01% |
+2,405
| New | +$130K |
|
3060
Destination XL Group
DXLG
$35.4M
| $115K | ﹤0.01% |
79,083
-3,068
| -4% | -$7.18K |
|
3061
America Movil
AMX
$71.2B
| $115K | ﹤0.01% |
8,117
-5,749
| -41% | -$82.4K |
|
3062
iShares MSCI Germany ETF
EWG
$1.62B
| $115K | ﹤0.01% |
3,105
+1,930
| +164% | +$69K |
|
3063
AudioEye
AEYE
$75M
| $115K | ﹤0.01% |
10,360
+1,313
| +15% | +$19.8K |
|
3064
Sanara MedTech
SMTI
$313M
| $115K | ﹤0.01% |
3,714
+483
| +15% | +$16.4K |
|
3065
Neumora Therapeutics
NMRA
$302M
| $114K | ﹤0.01% |
114,458
+1,718
| +2% | +$2.94K |
|
3066
JFrog
FROG
$10.8B
| $114K | ﹤0.01% |
3,559
+100
| +3% | +$3.48K |
|
3067
Contango Silver & Gold Inc
CTGO
$652M
| $114K | ﹤0.01% |
11,148
-1,796
| -14% | -$18.3K |
|
|
AXIA
3068
DELISTED
AXIA Energia
AXIA
| $113K | ﹤0.01% |
20,174
-16,244
| -45% | -$82.6K |
|
3069
Puma Biotechnology
PBYI
$454M
| $113K | ﹤0.01% |
38,295
+4
| +0% | +$13 |
|
3070
Achieve Life Sciences
ACHV
$683M
| $113K | ﹤0.01% |
42,267
+1,497
| +4% | +$4.66K |
|
3071
Arq
ARQ
$89.3M
| $112K | ﹤0.01% |
26,919
-1,532
| -5% | -$8.69K |
|
3072
Hooker Furnishings Corp
HOFT
$166M
| $111K | ﹤0.01% |
11,101
-743
| -6% | -$9.39K |
|
3073
MacroGenics
MGNX
$257M
| $111K | ﹤0.01% |
87,215
+1,998
| +2% | +$5.22K |
|
3074
Harmony Gold Mining
HMY
$12.3B
| $110K | ﹤0.01% |
7,444
-13,618
| -65% | -$152K |
|
3075
Cadiz
CDZI
$291M
| $109K | ﹤0.01% |
37,238
+2,680
| +8% | +$11.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2025 Portfolio in Review
As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
- RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
- RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
- RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
- RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
- RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
- RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.
Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.